Neogenesis vs. apoptosis As main components of pancreatic beta cell ass changes in glucose-infused normal and mildly diabetic adult rats
- PMID: 10385610
- DOI: 10.1096/fasebj.13.10.1195
Neogenesis vs. apoptosis As main components of pancreatic beta cell ass changes in glucose-infused normal and mildly diabetic adult rats
Abstract
We have investigated in adult rats made mildly diabetic by a low dose of streptozotocin (35 mg/kg; STZ rats) and in nondiabetic rats (ND rats) the mechanisms leading to adaptive changes in the beta cell mass, during glucose infusion and several days after stopping infusion. As early as 24 h of glucose infusion, the beta cell mass was maximally increased in ND and STZ rats. In both groups, this increase was due mainly to a rapid activation of neogenesis of new endocrine cells rather than to an increase in beta cell proliferation. Seven days after stopping glucose infusion, the beta cell mass returned to basal values in both groups as a result of stimulation of beta cell apoptosis and a decrease in beta cell replication rate. In glucose-infused ND rats, changes in the beta cell mass were correlated to insulin secretion, whereas in STZ rats, insulin secretion in response to glucose was still impaired whatever the beta cell mass. In conclusion, the data stress the impressive plasticity of the endocrine pancreas of adult rats. They also show that changes in beta cell mass in ND and STZ rats resulted from a disruption in the balance between neogenesis and apoptosis.
Similar articles
-
Pancreatic beta-cell regeneration after 48-h glucose infusion in mildly diabetic rats is not correlated with functional improvement.Diabetes. 1998 Jul;47(7):1058-65. doi: 10.2337/diabetes.47.7.1058. Diabetes. 1998. PMID: 9648829
-
Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.Diabetes. 2001 Jul;50(7):1562-70. doi: 10.2337/diabetes.50.7.1562. Diabetes. 2001. PMID: 11423477
-
Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.Diabetes. 2003 Mar;52(3):741-50. doi: 10.2337/diabetes.52.3.741. Diabetes. 2003. PMID: 12606516
-
Islet cell neogenesis in the pancreas.Virchows Arch. 1996 Mar;427(6):553-60. doi: 10.1007/BF00202885. Virchows Arch. 1996. PMID: 8605565 Review.
-
β-cell mass in people with type 2 diabetes.J Diabetes Investig. 2011 Jan 24;2(1):6-17. doi: 10.1111/j.2040-1124.2010.00072.x. J Diabetes Investig. 2011. PMID: 24843456 Free PMC article. Review.
Cited by
-
Mechanistic insights into pancreatic beta-cell mass regulation by glucose and free fatty acids.Anat Cell Biol. 2015 Mar;48(1):16-24. doi: 10.5115/acb.2015.48.1.16. Epub 2015 Mar 20. Anat Cell Biol. 2015. PMID: 25806118 Free PMC article. Review.
-
Gynura divaricata rich in 3, 5-/4, 5-dicaffeoylquinic acid and chlorogenic acid reduces islet cell apoptosis and improves pancreatic function in type 2 diabetic mice.Nutr Metab (Lond). 2018 Oct 10;15:73. doi: 10.1186/s12986-018-0310-y. eCollection 2018. Nutr Metab (Lond). 2018. PMID: 30337946 Free PMC article.
-
Mild diabetes: long-term effects on gastric motility evaluated in rats.Int J Exp Pathol. 2018 Feb;99(1):29-37. doi: 10.1111/iep.12262. Epub 2018 Feb 26. Int J Exp Pathol. 2018. PMID: 29479759 Free PMC article.
-
Microarray analysis of somatostatin receptor 5-regulated gene expression profiles in murine pancreas.World J Surg. 2009 Apr;33(4):630-7. doi: 10.1007/s00268-008-9893-1. World J Surg. 2009. PMID: 19137362
-
Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes.Diabetologia. 2004 Apr;47(4):686-94. doi: 10.1007/s00125-004-1372-0. Diabetologia. 2004. PMID: 15298346
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous